drugset / Trial / NCT05737771
To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
RandomizedCrossoverOpen-labelTreatment
Summary
To compare the safety and pharmacokinetic properties between the administration of DWP16001 and DWC202213 as an individual drug, and the administration of DWJ1563 as a combination drug.
Timeline
- Start
- 2023-01-25
- Primary completion
- 2023-03-31
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWC202213 | Unknown | — | — |
| Subject | DWJ1563 | Unknown | — | — |
| Subject | Enavogliflozin | Small molecule | — | — |